ALL
37
3
HST
53
4
CINF
24
-8
KIM
58
2
GS
65
16
PBI
30
-8
AA
27
5
EQIX
59
2
HCA
37
7
BDX
59
3
WU
26
2
SYF
78
7
CRM
65
6
HAL
40
11
EXPE
83
8
WMB
58
3
LB
16
9
DVA
62
5
STT
48
4
CMCSA
49
3
ALL
37
3
HST
53
4
CINF
24
-8
KIM
58
2
GS
65
16
PBI
30
-8
AA
27
5
EQIX
59
2
HCA
37
7
BDX
59
3
WU
26
2
SYF
78
7
CRM
65
6
HAL
40
11
EXPE
83
8
WMB
58
3
LB
16
9
DVA
62
5
STT
48
4
CMCSA
49
3
Financhill
Back

Brown & Brown Vs. Kymera Therapeutics Industry Stock Comparison

Buy
57

BRO
Brown & Brown

Last Price:
$102.81
Seasonality Move:
5.02%
Sell
39

KYMR
Kymera Therapeutics

Last Price:
$40.75
Seasonality Move:
2.79%
Buy
57
Brown & Brown (BRO) is a Buy

Is Brown & Brown a Buy, Sell or Hold?

  • The current Brown & Brown [BRO] share price is $102.93. The Score for BRO is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
  • BRO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
39
Kymera Therapeutics (KYMR) is a Sell

Is Kymera Therapeutics a Buy, Sell or Hold?

  • The current Kymera Therapeutics [KYMR] share price is $40.64. The Score for KYMR is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • KYMR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

BRO Stock Price Chart

What is Brown & Brown's stock price today?

  • The Brown & Brown share price today is $102.93
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BRO is experiencing slight buying pressure.

KYMR Stock Price Chart

What is Kymera Therapeutics's stock price today?

  • The Kymera Therapeutics share price today is $40.64
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KYMR is experiencing buying pressure, which is a positive indicator for future bullish movement.

BRO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.85 Sell
Relative Strength Index (14 RSI): 37.6 Sell
Chaikin Money Flow: 111001 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (104.06 - 112.04) Sell
Bollinger Bands (100): (101.46 - 108.86) Sell

KYMR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.61 Sell
Relative Strength Index (14 RSI): 40.07 Sell
Chaikin Money Flow: 1023886 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (41.59 - 46.41) Sell
Bollinger Bands (100): (42.92 - 48.78) Sell

BRO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 103.21 Sell
20-day SMA: 107.58 Sell
50-day SMA: 107.59 Sell
200-day SMA: 96.69 Buy
8-day EMA: 103.57 Sell
20-day EMA: 105.9 Sell
50-day EMA: 106.52 Sell
200-day EMA: 97.48 Buy

KYMR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 41.68 Sell
20-day SMA: 44.26 Sell
50-day SMA: 45.89 Sell
200-day SMA: 41.31 Sell
8-day EMA: 41.51 Sell
20-day EMA: 43.39 Sell
50-day EMA: 44.87 Sell
200-day EMA: 41.09 Sell

Brown & Brown Earnings Growth & BRO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.12 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.02 per share, and an increase next year of $0.34 per share.

Kymera Therapeutics Earnings Growth & KYMR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.12 per share, and a decrease next year of $0.37 per share.

Brown & Brown Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Kymera Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):